Ancora Advisors, LLC Globe Star Therapeutics Corp Transaction History

Ancora Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.01 - $0.02 $880 - $1,760	88,000 New	88,000 $1,000
Q1 2022 May 13, 2022	SELL	$0.01 - $0.02 $880 - $1,760	-88,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.01 - $0.03 $360 - $1,080	36,000 Added 69.23%	88,000 $1,000
Q3 2021 Nov 15, 2021	BUY	$0.03 - $0.07 $1,560 - $3,640	52,000 New	52,000 $2,000

Ticker GSTC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 693,996,992
Description
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.